Genmab is an international biotech company with 24 years of experience in developing cutting-edge antibodies and antibody technology. Please join Mark Peters II, Shannon Stempkowski, Wendy Interiano, and Jenny Fox as they discuss Genmab’s vision and approach to developing innovative patient support programs and advocacy initiatives to support people with cancer, incorporating the patient voice at every step of the way.
